Benefit of Latanoprostene Bunod (Vyzulta) for Glaucoma Switched from Prior Pharmacotherapy: A Retrospective Cohort Study in Taiwan.

Ophthalmol Ther · 2026 · PMC13249998 · PMID 41991793

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Overall, the mean IOP was 16.4 ± 4.2 mmHg at baseline, 14.7 ± 3.6 mmHg at 1 month, 14.9 ± 3.7 mmHg at 3 months, 14.7 ± 3.6 mmHg at 6 months, and 14.0 ± 2.3 mmHg at 1 year, indicating a decreasing trend.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.